1. PRMT5 Mediated HIF1α Signaling and Ras-Related Nuclear Protein as Promising Biomarker in Hepatocellular Carcinoma.
- Author
-
Abumustafa, Wafaa, Castven, Darko, Sharif-Askari, Fatemeh Saheb, Abi Zamer, Batoul, Hamad, Mawieh, Marquardt, Jens-Uwe, and Muhammad, Jibran Sualeh
- Subjects
- *
NUCLEAR proteins , *HEPATOCELLULAR carcinoma , *BIOMARKERS , *GENE expression , *RAS oncogenes , *OVERALL survival , *METHYLGUANINE - Abstract
Simple Summary: The protein arginine N-methyltransferase 5 (PRMT5) has been identified as a promising therapeutic target in various cancers. However, its role in hepatocellular carcinoma (HCC) development has not yet been investigated. This study aims to understand PRMT5′s impact on overall survival, signaling pathways, and downstream gene expression using in silico public databases and our in-house NGS data. Our results revealed an increase in PRMT5 expression in HCC compared to normal liver tissue, and this elevated expression was associated with poorer patient outcomes. Analysis of promoter CpG islands and methylation status suggested potential epigenetic mechanisms driving PRMT5 overexpression in HCC. Pathway analyses found a link between PRMT5 expression and the HIF1α pathway, with Ras-related nuclear protein (RAN) identified as a potential target of PRMT5 in HCC. Protein arginine N-methyltransferase 5 (PRMT5) has been identified as a potential therapeutic target for various cancer types. However, its role in regulating the hepatocellular carcinoma (HCC) transcriptome remains poorly understood. In this study, publicly available databases were employed to investigate PRMT5 expression, its correlation with overall survival, targeted pathways, and genes of interest in HCC. Additionally, we utilized in-house generated NGS data to explore PRMT5 expression in dysplastic nodules compared to hepatocellular carcinoma. Our findings revealed that PRMT5 is significantly overexpressed in HCC compared to normal liver, and elevated expression correlates with poor overall survival. To gain insights into the mechanism driving PRMT5 overexpression in HCC, we analyzed promoter CpG islands and methylation status in HCC compared to normal tissues. Pathway analysis of PRMT5 knockdown in the HCC cells revealed a connection between PRMT5 expression and genes related to the HIF1α pathway. Additionally, by filtering PRMT5-correlated genes within the HIF1α pathway and selecting up/downregulated genes in HCC patients, we identified Ras-related nuclear protein (RAN) as a target associated with overall survival. For the first time, we report that PRMT5 is implicated in the regulation of HIF1A and RAN genes, suggesting the potential prognostic utility of PRMT5 in HCC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF